Bisphosphonates in the treatment of metabolic bone diseases

被引：13

作者：

Arantes, Henrique Pierotti ^{[1
]}

da Silva, Andre Goncalves ^{[1
]}

Lazaretti-Castro, Marise ^{[1
]}

机构：

[1] Univ Fed Sao Paulo Unifesp, Unidade Metab Osseo & Mineral, Dept Endocrinol, Sao Paulo, Brazil

来源：

ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA | 2010年 / 54卷 / 02期

关键词：

Bisphosphonates; mechanism of action; osteoporosis treatment; side effects; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL OSTEOPOROSIS; ZOLEDRONIC ACID; ORAL IBANDRONATE; MINERAL DENSITY; HIP FRACTURE; WOMEN; ALENDRONATE; RISEDRONATE;

D O I：

10.1590/S0004-27302010000200017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Osteoporosis is a disease characterized by low bone mass associated with the deterioration of microarchitecture, due to an imbalance either in high bone resorption or low bone formation or in both, leading to a high risk of fractures. Bisphosphonates are medications which reduce the ability of osteoclasts to induce bone resorption and consequently improve the balance between resorption and formation. There are bisphosphonates approved for the prevention and treatment of osteoporosis. Administration can be oral (daily, weekly or monthly) or intravenous (quarterly or yearly). These medications are well tolerated and with the correct instructions of administration have a good safety profile. Serious side effects, such as, osteonecrosis of jaw is very rare. Bisphosphonates are the most prescribed medication for the treatment of osteoporosis. Arq Bras Endocrinol Metab. 2010;54(2):206-12

引用

页码：206 / 212

页数：7

共 48 条

[1] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].

Black, Dennis M. ;

Delmas, Pierre D. ;

Eastell, Richard ;

Reid, Ian R. ;

Boonen, Steven ;

Cauley, Jane A. ;

Cosman, Felicia ;

Lakatos, Peter ;

Leung, Ping Chung ;

Man, Zulema ;

Mautalen, Carlos ;

Mesenbrink, Peter ;

Hu, Huilin ;

Caminis, John ;

Tong, Karen ;

Rosario-Jansen, Theresa ;

Krasnow, Joel ;

Hue, Trisha F. ;

Sellmeyer, Deborah ;

Eriksen, Erik Fink ;

Cummings, Steven R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822

[2] Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].

Black, Dennis M. ;

Schwartz, Ann V. ;

Ensrud, Kristine E. ;

Cauley, Jane A. ;

Levis, Silvina ;

Quandt, Sara A. ;

Satterfield, Suzanne ;

Wallace, Robert B. ;

Bauer, Douglas C. ;

Palermo, Lisa ;

Wehren, Lois E. ;

Lombardi, Antonio ;

Santora, Arthur C. ;

Cummings, Steven R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938

[3] Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].

Bone, HG ;

Hosking, D ;

Devogelaer, J ;

Tucci, JR ;

Emkey, RD ;

Tonino, RP ;

Rodriguez-Portales, JA ;

Downs, RW ;

Gupta, J ;

Santora, AC ;

Liberman, UA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199

[4] The impact of compliance with osteoporosis therapy on fracture rates in actual practice [J].

Caro, JJ ;

Ishak, KJ ;

Huybrechts, KF ;

Raggio, G ;

Naujoks, C .

OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) :1003-1008

[5] Mortality after all major types of osteoporotic fracture in men and women: an observational study [J].

Center, JR ;

Nguyen, TV ;

Schneider, D ;

Sambrook, PN ;

Eisman, JA .

LANCET, 1999, 353 (9156) :878-882

[6]

Chang JT, 2003, NEW ENGL J MED, V349, P1676

[7] Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE [J].

Chesnut, CH ;

Ettinger, MP ;

Miller, PD ;

Baylink, DJ ;

Emkey, R ;

Harris, ST ;

Wasnich, RD ;

Watts, NB ;

Schimmer, RC ;

Recker, RR .

CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (03) :391-401

[8] Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis [J].

Chesnut, CH ;

Skag, A ;

Christiansen, C ;

Recker, R ;

Stakkestad, JA ;

Hoiseth, A ;

Felsenberg, D ;

Huss, H ;

Gilbride, J ;

Schimmer, RC ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1241-1249

[9] Osteoporosis after solid organ and bone marrow transplantation [J].

Cohen, A ;

Shane, E .

OSTEOPOROSIS INTERNATIONAL, 2003, 14 (08) :617-630

[10] Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK [J].

Compston, J. ;

Cooper, A. ;

Cooper, C. ;

Francis, R. ;

Kanis, J. A. ;

Marsh, D. ;

McCloskey, E. V. ;

Reid, D. M. ;

Selby, P. ;

Wilkins, M. .

MATURITAS, 2009, 62 (02) :105-108

← 1 2 3 4 5 →